Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

President Urges Breaking Down Of Drug, Device Distinctions, Regulatory Barriers

This article was originally published in The Gray Sheet

Executive Summary

The White House held a summit on its Precision Medicine Initiative where President Obama emphasized the need to break down outmoded regulations, and suggested that the barriers between drug and device oversight need to be loosened. Also at the meeting: FDA and NIH announced new competitions and projects, including the launch of an effort to gather data from a million Americans over the next few years.

Advertisement

Related Content

FDA Reorganization Advocates Seek Senate Boost For Disease-Oriented Structure
Precision Medicine Plan 'Golden Opportunity' For Device, Diagnostic Firms

Topics

Advertisement
UsernamePublicRestriction

Register

MT035004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel